International Gen Ins Hl LTD
International General Insurance, IGIC, trades at 8.9x LTM earnings and 1.5x tangible book value, with a $1.1 billion market capitalization…
Archive
1293 storiesMay 4 – May 7
Thursday, May 7 3 stories
Timyan Bank Alert on X
Stilwell group nominee for $PFBX board inches closer every year. https://t.co/nT7keZuDLT
Little Owl Research on X
My report on $RAVE for anyone interested. https://t.co/heQF6riN6X
Wednesday, May 6 6 stories
Vislink Technologies INC
Vislink Technologies trades near cash after turning EBITDA-positive through a defense communications pivot under DoD Trusted Investor…
Middleby CORP
Middleby trades at about 11 times EBITDA, below its history and peers, as a sharper management focus is expected to address the commercial…
Psyop Capital on X
https://t.co/T8yX0dSc2e $OTCM rev +15% EBIT +19%
Genuine Parts CO
Genuine Parts trades at roughly 9x EBITDA as cyclical weakness and elevated NAPA investment temporarily depress earnings.
Fierce_beast on X
11 reasons for why i'm long $goog: https://t.co/2HTd3mVPKx
ToffCap on X
Marex $MRX Q1 rev +48% yoy, EPS +55% https://t.co/bYO0DYYPjF
Tuesday, May 5 8 stories
Aaon INC (aaon)
AAON is presented as a long investment idea, revisiting a company written up as a short nearly a decade ago.
Rush Street Interactive INC
Rush Street Interactive (RSI) is presented as a long investment idea.
Psyop Capital on X
@finphysnerd $cme and $otcm are in this category and are reasonable
Timyan Bank Alert on X
Fresh $CFFN 13d by @HoldCoAM https://t.co/ecXNkAUTeX
Ambase CORP
Ambase Corp.'s November 30, 2026 consolidated bench trial is the key catalyst for its litigation stub after the nearly sold-out 111 West…
Timyan Bank Alert on X
@JustBankStocks @StocksOddball Even happier 39 month and two week $FSEA anniversary. Congrats to you!
Timyan Bank Alert on X
@thebankzhar @SteveChuck5 There are many candidates for $BANR to pursue next. $CSHX $CWBC $OVLY $PVBK $SFBC the list is endless. https://t.co/ssMeFndZzi
Timyan Bank Alert on X
In Play Today: UMB Financial $UMBF reiterates future M&A requirements; Blue Owl rejects buyout offer | S&P Global Market Intelligence https://t.co/qDTqHhJTSr
Monday, May 4 7 stories
Stryker CORP
Stryker (SYK) trades near a 52-week low after a late-Q1 cyberattack disrupted revenue and earnings, framing a long-term compounder…
Adobe Expert Insight Interview (No Paywall)
Adobe trades at 11x earnings despite $24.5 billion of revenue, 37% operating margins and 12% profit growth; a former data-science head…
Tim Eriksen on X
Datatrak’s unaudited annual report contains cash-flow inaccuracies, raises fraud concerns and follows years of heavy shareholder dilution.
PayPal tries again (and again)
Stripe’s startup-focused product sprawl contrasts with Adyen’s enterprise restraint; despite 20% more payment volume and faster growth,…
Cue Biopharma
Cue Biopharma faces a deteriorating balance sheet, recurring operating losses, ATM dilution and PIPE-investor selling pressure.
